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ABSTRACT
The  lethal  actions  of mitomycin  C  and  actinomycin  D  were followed  during  the  division
cycle  of HeLa cells.  The  cells  were  most susceptible  to a  2 hr pulse of mitomycin C  during
the  G1  phase,  whereas  their  sensitivity  to  actinomycin  D  was  most  pronounced  in  the  S
phase.  Posttreatment  of the  cells  with acetoxycycloheximide,  a  potent inhibitor of protein
synthesis,  increased  the survival  (colony-forming  ability)  of cells  treated with  mitomycin  C
but had  very  little  effect  on  the survival  of  cells  treated  with actinomycin  D.  The  signifi-
cance  of  these findings  is  discussed.
INTRODUCTION
That  certain  chemicals  have  different  toxicities
with  respect  to  the  various  stages  of the  cell  divi-
sion  cycle  has  been  observed  in  several  types  of
mammalian  cells  in  culture  (1-5).  Treating  syn-
chronous  cells  with  specifically  acting  chemicals
and  observing  fluctuations  in  their  survival  may
be  a  possible  means  of gaining insight  into altera-
tions  in vital  cell constituents during the cell  cycle.
In  the  present  investigation,  we  studied  the
lethal  effects  of mitomycin  C  and  actinomycin  D
on  synchronous  HeLa  cells  in terms  of cell  colony
formation.  Both  of these  antibiotics  are  known  to
affect  DNA,  but each  in  a different  manner.  We
also studied  the  effect  of acetoxycycloheximide,  an
inhibitor of protein synthesis, on these treated  cells.
Acetoxycycloheximide  was  found  to  reverse,  to
some  extent,  the  lethal  effects  of  mitomycin  C,
much in  the  fashion  of the  restorative  effect  it has
on X-irradiated  cells.'  Similarly,  excess thymidine
at  a  concentration  which  inhibits  DNA  synthesis
(6,  7)  had  a  restorative  effect  on  mitomycin
C-treated  cells.
MATERIALS  AND  METHODS
The  HeLa  S-3  cells  used  in  this  study  were  main-
tained in Eagle's  medium supplemented  with  0.1  mM
nonessential  amino  acids  and  10%  calf serum.  Cul-
ture conditions, scoring survival by colony formation,
maintenance,  and  media  composition  have  been  de-
scribed  elsewhere  (7,  8).
1 Synchronous  cultures  were
initiated  by  plating  mitotic  cells  which  had  been
selectively  removed  by  controlled  agitation  from  a
monolayer  of  cells  in  Ca2+-deficient  medium  (8).
Mitomycin  C  or  actinomycin  D  was  added  to  fresh
'Djordjevic,  B.,  J.  H.  Kim,  and  S.  H.  Kim.  1968.
Modification  of radiation  response  in  synchronized
HeLa  cells  by  metabolic  inhibitors.  In  preparation.
477medium  shortly  before  each  experiment,  and  this
supplemented  medium was  added  to emptied  dishes
at specified  times. Acetoxycycloheximide  (ACH)  and
thymidine  (TdR)  were  added  directly  to  medium
from  a  50X  stock  solution  to yield  the desired  final
concentrations.  The drugs  were  added  after the  cells
had become  attached; a 3 hr period after plating  was
allowed  for  cell  attachment.
Incorporation  of  tritiated  precursors  for  estima-
tion  of  DNA,  RNA,  and  protein  synthesis  was
studied  in 5-10  X  104 randomly dividing  cells in the
absence  or  presence  of  mitomycin  C  for  certain
periods of time.  The cells  were harvested  by trypsini-
zation and filtered on millipore filters as outlined pre-
viously  (5).  The  filter  was  suspended  in  5  ml  of
toluene  containing  4  g/liter  2,5-diphenyloxazole
(PPO) and 50 mg/liter  ,4-bis[2-(5-phenyloxazolyl)]-
benzene  (POPOP)  and counted  in  a  liquid  scin-
tillation counter.
RESULTS
Effects of Drug Concentration and Duration  of
Treatment on Colony Formation in Randomly
Dividing Cells
To determine  the dose response  of HeLa  cells to
mitomycin  C  and  actinomycin  D,  randomly  di-
viding  cells  were exposed  to several  different  con-
centrations  of each  antibiotic  for  various  periods
of  time.  Typical  dose-survival  curves  were  ob-
tained,  as  shown  in  Figs.  I  and  2.  Mitomycin  C
displays  a  disproportionally  small  effect  at  short
exposure  times  as compared  to  longer  times;  that
is,  a  shoulder  region  is  evident  in  the  survival
curve  (Fig.  1).  Actinomycin  D  reduces  cell  via-
bility (colony-forming  ability) exponentially,  since
there  is  no  apparent  shoulder  in  the  curve  when
survival  is  plotted  semilogarithmically  as  a  func-
tion of exposure  to this compound  (Fig.  2). On the
basis  of  these  results,  for  further  experiments  a
time of exposure  to the  two  antibiotics  was  chosen
which  is  long  enough  to  encompass  the  shoulder
region  of the  curve  (in  the  case  of mitomycin  C),
yet  short  enough  to  permit  a  reasonable  correla-
tion of drug action  with particular metabolic land-
marks  in  the  division  cycle.  Accordingly,  a  2-hr
incubation  with  these  antibiotics  was  chosen  for
the  treatment  of synchronous  cells.
Effect  of Mitomycin  C on Synthesis of DNA,
RNA,  and Protein
A  series  of  18-hr  random  cultures  of  HeLa
cells  was  exposed  to  0.1  g/ml  mitomycin  C
Hour
FIGURE  1  Survival  (colony-forming  ability)  in  ran-
domly dividing HeLa  cells exposed to different  concen-
trations  of  mitomycin  C  for  different  periods  of  time.
Drug was  added to cells  18 hr after plating.
together  with  thymidine-3H,  uridine-
3H,  or  val-
ine-
3H  for  different  periods  of  time.  A  control
series  was  similarly  set  up  but  without  the  anti-
biotic.  It  is  evident  from  the  results  shown  in
Table  I  that  macromolecular  synthesis  of DNA,
RNA,  and  protein  is  relatively  insensitive  to  the
drug  during  the  first  few  hours  of  treatment.
This result  is in  agreement  with findings  on  other
cultured  mammalian  cells  treated  with  mito-
mycin C  (9).
Fluctuations  of Lethal Effects of Mitomycin  C
and  Actinomycin  D  During  Cell  Division
Cycle; Effect of Acetoxycycloheximide in
Modifying Toxicity of these Antibiotics
Fig.  3  shows  the  survival  of synchronous  HeLa
cells  exposed  for  2  hr  to  mitomycin  C  or  actino-
mycin D during the  division cycle.  The  two drugs
differ  considerably  in  toxicity pattern  (in terms  of
inactivation  of  colony-forming  ability);  mito-
mycin  C  is  maximally  effective  in  killing  HeLa
cells  when  they  are  in  the  G  phase,  whereas
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-actinomycin  D is most toxic to the cells in the early
part  of their  synthetic  (S)  phase.
In  a  further  effort  to  characterize  the  cyclic
response  of cells to the  lethal actions  of mitomycin
0  2  4  6
Hou  r
FIGURE 2  Survival  in  randomly  dividing  HeLa  cells
exposed  to various  concentrations  of actinomycin  D for
different  periods of time. Drug was added to cells  18 hr
after plating.
C  and  actinomycin  D,  G 2-phase  cells  were  se-
lected  by  means of the combined  action of thymi-
dine-
3H and vinblastine  (5,  10,  11),  and  the  effects
on  these  cells  of  mitomycin  C  and  actinomycin
D  were  examined.  The  method  consists  of treat-
ing  cells  with  thymidine-
3 H  of  high  specific  ac-
tivity  (2  puc/ml  medium,  14  c/mmole),  which
selectively  kills  S-phase  cells  during  a  1 hr treat-
ment,  and  with  vinblastine  sulfate  (0.03  g/ml)
which  does  not  interfere  with  cell  progression
through  the  interphase  but arrests  cells  in  meta-
phase  when they  are easily  removed  from the  rest
of the  population.  S-phase  cells  were  also  selected
by treating  synchronous  cultures  with  a  combina-
tion  of  a  high  concentration  of  nonradioactive
thymidine  and  vinblastine,  as  described  earlier
(5).  Table  II  shows  that,  relative  to  the  response
shown  by  S-phase  cells,  the  sensitivity  of  G2-
phase  cells  to  mitomycin  C  increases,  but  their
sensitivity  to  actinomycin  D  decreases  although
the  differences  are  not  large.
The  restorative  effect  of acetoxycycloheximide
(ACH)  when  added  to  cells  after  treatment  with
mitomycin  C  is  shown  in  Fig.  4.  ACH  strongly
inhibits  synthesis of protein  and,  to a lesser extent,
of DNA,  but it has little effect  on RNA synthesis.
As  can  be  seen  from  Fig. 4,  ACH  restores viabil-
ity  to  mitomycin-treated  cells;  it  has  very  little
effect  on  actinomycin-treated  cells  (data  not
shown).
TABLE  I
Incorporation of Labeled Precursors into DNA,  RNA,  and Protein of HeLa  Cells in  the
Presence of Mitonzycin C
Thymidine-aH  Uridie-aH  Valine-3H
Incubation  Mitomycin  Mitomycin  Mitomycin
time  Control  treated  Control  treated  Control  treated
hr
1.0  4,967*
2.0  11,410
3.0  15,675
4.0  18,758
5,292
10,576
15,267
16,515
6,016
12,095
27,087
40,690
7,916
14,163
24,801
31,617
285
693
997
1,320
311
552
959
1,388
Labeled  precursors  (thymidine-3H:  0.5  tc/ml,  13.0  c/mmole;  uridine-3H:  1  uc/ml,
9.0 c/mmole;  valine-3H:  1 Mc/ml,  4.0 c/mmole)  were added  to about 5  X  104 randomly
dividing  cells  18  hr  after  plating  with  or  without 0.1  g/ml mitomycin  C.  At  time
intervals,  cells  were  harvested  by  trypsinization,  and  their  radioactivity  was  deter-
mined  as  outlined  in Materials  and Methods.
* Figures  are counts per  minute per  plate.
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Iaccordance  with  the  view  that  posttreatment
with  ACH favors repair.
DISCUSSION
That  there  are  differences  in the  lethal actions  of
mitomycin  C and  actinomycin  D during  the  divi-
sion  cycle  of HeLa  cells  is  not  surprising  in  view
of the  different  modes  of  action  of  the  two  anti-
biotics.  Whereas  the  toxicity  of  mitomycin  C  is
greatest during the  early  phases  (G1 )  of the  cycle,
that  of  actinomycin  D  is  highest  in  the  early
part of the  S  phase. The  fact that both mitomycin
C  and actinomvcin  D form  omulexes with  native
DNA  may  account  for  their  toxic  actions.  Al-
though  mitomycin  C  will  bind  to  other  cell
constituents  (12),  its  lethal  action,  at  least  in
bacteria,  is  thought  to  result  from  its  ability  to
cross-link  complementary  DNA  strands  (13).
Actinomycin  D  binds  specifically  to  DNA,  owing
to  the  unique  stereochemical  properties  of  the
antibiotic  and  the  macromolecule  (14,  15).
The  observed  toxicity  variations  during  the
n
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4
0
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FIGURE 3  Survival  of  synchronously  growing
cells  exposed  to  0.1  jug/ml  of  mitomycin  C  (i
0.3  g/ml  of actinomycin  D  (A.D.) for 2  hr dur
ferent  parts  of the division cycle  (upper graph)
graph:  DNA  synthesis in the  same culture  as m
by  the  incorporation  of  thyrmidine-
3 H  during
pulses at different times during the cycle.
Modification of the Lethal Effect of Mit
C by Pretreatment  of Synchronized
Cells with Metabolic Inhibitors
It  was  of  interest  to  determine  whether
treatment  given  before  treatment  with mite
C  has  a  modifying  effect  on  cell  survival
to  that  produced  when  ACH  is  given  afte;
ment  with mitomycin  C.  At  8  hr  after  the
tion  of the  culture,  synchronous  cells  were
for  2  hr  with  mitomycin  C.  ACH,  and/(
10
-3  M thymidine,  also  active  in  restoring
ated  cells,'  were  included  in  the 3rd-8th h
pretreatment  effects  were  being  tested  and
l0th-l13th  hr  when  posttreatment  effect
being examined.
Table  III  shows  that  the  pretreatment
with  ACH  has  little  effect  on  mitomyc
caused  lethality  compared  with  its effect fol
mitomycin  C  treatment.  Such  a  findin 1
25  cycle  lgnt  De  explalleC  in  severat  ways:  a,  cenl
permeability  to  drugs  may  vary;  b,  accessibility
g  IIeLa  of  DNA  in  chromosomal  structures  may  vary
I.C.)  or  during  the cycle,  e.g.  receptive  sites on  the macro-
ring dif-
. Lower
ensured  TABLE  II aeasued
30-min  Lethal Effects  of Mitomycin  C and Actinomycin  D
on  "Purified" S-phase and G 2-phase Cells
)mycin
r ACH
.omycin
similar
r  treat-
s initia-
treated
or  2  X
irradi-
r when
I in  the
s  were
of  cells
cin  C-
lowing
g  is  in
Survival  of corresponding  controls
Supplements  Mitomycin  C  Actinomycin D
(20 22 hr)  (20-22  hr)
%  %
No supplement  19.4  57
VLB 3-20  hr  33.0  61.8
TDR  16-20  hr
VLB 3-20  hr  20.6  71.5
TDR-3H  19-20 hr
G 2 cells  were  selected  by  treating  mitotically syn-
chronized  cells  with  a  combination  of vinblastine
sulfate  (VLB, 0.03  Mg/ml)  and  tritiated  thymidine
of  high  specific  activity  (TDR-3H,  2  c/ml,  14
c/mmole)  as  described  previously  (11).  S-phase
cells  were  selected  by  treating  synchronous  cells
with  a  combination of VLB  and  excess  thymidine
(TDR,  500  Mg/ml).  Hours  indicate  time  elapsed
between  the  initiation  of synchronous  culture  and
the  particular  treatment  performed.  Concentra-
tion of drugs:  mitomycin  C: 0.1  Mg/ml;  actinomy-
cin  D: 0.1  Mig/ml.
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FIGURE 4  Survival  of  synchronous  cells  aft
pulse treatment with  0.1 /g/ml  of mitomycin  C
during different parts of the division cycle,  with (
out subsequent  8-hour treatment  with 5  pug/ml
oxycycloheximide  (upper graph).  DNA synthesis
sane culture is shown in the lower graph.
molecule may  be  changed  by contraction  o
mosomes  or  masked  by  products  of  its  te
activity;  c, intrinsic  sensitivity  of the DNA
cule  may  itself  vary;  and  d,  posttreatment
processes  may  be  acting  in  a  different  n
during  the  cycle.  Possibility  a,  that  char
permeability  may  be  so  finely  regulated
govern  the  precise  amount  of antibiotic  de
to  the  sensitive  sites  in  the  cell,  seems  un
Possibility  d may have  some  importance,  bt
probably  in  conjunction  with  processes  o
in  possibilities  b and  c, as will  be  discussed
It  is  tempting  to  speculate  that  the  del
damage  caused  by  some  toxic  chemicals  d
on  the  physical  state  of DNA.  It  has  been
(16)  that  the  physical  state  of DNA  une
changes  in  vivo,  i.e.  that  the  macromole
transiently  and  partially  denatured  in  pi
it  has  been  postulated  that  the  biological  effect
of  bifunctional  alkylating  agents  (e.g.  nitrogen
mustard,  mitomycin  C)  is  due  to  the  formation
of interstrand  cross-links,  i.e.  linkage  across  com-
plementary  strands in DNA. It  may be speculated
that  mitomycin  C  cross-links  DNA  to  a  greater
extent earlier in G1, when the strands of the macro-
molecule  are  in  a  more  favorable juxtaposition.
With  actinomycin D,  the  foregoing  considerations
may  not  apply;  instead,  processes  participating
in  repair  may  be  critical  in  the  toxicity  of  this
antibiotic.  Such  a  situation  could  exist  when
partially  separated  strands  (e.g.  during  S)  are
inactivated  and  thus  interfere  with  the  caoacitv
of both  the  damaged  and the undamaged  strands
to  copy  from  each  other.  On  the  other  hand,
while  there  seems  to be  good correlation  between
cross-linking  and  the  lethal  action  of  mitomycin
C  in  bacteria  (13),  very  little  cross-linking  was
found  in  DNA  isolated  from  inactivated  D98S
cells  (17).  Moreover,  much  of  the  lethal  effect
could  be  reversed  by  parallel  or  even  delayed
treatment  with NaBH 4 (18).  These  observations,
mitomycin  C  may  be  somewhat reversed  by  post-
treatment  with  ACH,  argue  against  the  effect
ter  -hr  of  cross-linking,  thought  to  be  an  irreparable
(M.C.)  process  (19),  as  the  sole  cause  of  lethal  action.
or with-
of acet-
s in the  TABLE  III
Effect  of Combined Treatment  by Mitomycin  C and
Acetoxycycloheximide  or Excess Thymidine  on
Survival of HeLa Cells
f  chro-
mplate
mole-
repair
nanner
iges  in
as  to
livered
likely.
It most
utlined
below.
agree  of
epends
shown
lergoes
cule  is
repara-
Survival  of cells treated  by mitomycin  C*
Compounds
Pretreatment:  Posttreatmentj
None  2.8  2.8
ACH  4.4  13.9
TDR  3.7  9.4
* Cells were  incubated  with  0.1  /g/ml  of  mitomy-
cin C 8-10 hr after  plating the mitotically synchro-
nized cells. Corresponding  controls with additional
treatment  (ACH or TDR only) were taken as 100%.
I Pretreatment consisted  of incubating  cells 3-8 hr
with  acetoxycycloheximide  (ACH,  5  jig/ml)  or
thymidine  (TDR,  500  g/ml).
§ Posttreatment  consisted  of  incubating  cells
10-13  hr  after initiating synchronous  cultures  with
the  above  concentrations  of ACH  or TDR.
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_At the  relatively  low  concentration  of mitomy-
cin  C used  in  this study,  the lethal effects  may  be
also exerted by alkylation  of membranes and other
cytoplasmic  components  (17).  Such  processes
may  require  more  time  to  be  effective  and  are
reflected  in  the  sigmoidal  shape  of  the  survival
curve  of cells  exposed  for  various  periods  of  time
to mitomycin  C.  Both  modes  of lethal action  may
actually  operate  in  mitomycin  C-treated  cells,
and  it  is  therefore  possible  that  the  periodic  fluc-
tuations  in lethal  action  during  the  cycle  are  due
to cross-linking  of DNA  strands,  while  the  repar-
able  portion  is  due  to  other  effects  of  mitomy-
cin C.
Again, it  is  hoped that further  experimentation
will  clarify  the  processes  leading  to  cell  death
after  treatment  with  mitomycin  C  and  actino-
mycin  D.
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